Examines C1q inhibition's impact on functional recovery in Guillain-Barré syndrome, suggesting early treatment enhances outcomes.
Determine whether C1q inhibition with tanruprubart improves functional recovery in Guillain-Barré syndrome (GBS), and whether effects are amplified with earlier treatment or in patients with limited axonal damage (consistent with motor forms of GBS).
No takes yet. Share an insight, caveat, or question.
Kroon et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: